{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:49:22Z","timestamp":1786981762091,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-03968-z","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T05:01:42Z","timestamp":1709874102000},"page":"2489-2494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of different alpha-receptor antagonists on metabolic parameters: a head-to-head comparison"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3908-6780","authenticated-orcid":false,"given":"L\u00fctfullah","family":"Ca\u015ftur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8754-1069","authenticated-orcid":false,"given":"Mehmet","family":"Uzunlulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8602-5940","authenticated-orcid":false,"given":"Erhan","family":"Eken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-3352","authenticated-orcid":false,"given":"Muhammed","family":"\u00c7i\u00e7ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5158-5630","authenticated-orcid":false,"given":"Ahmet","family":"Tahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4757-803X","authenticated-orcid":false,"given":"\u00d6zg\u00fcr","family":"Efilo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-8866","authenticated-orcid":false,"given":"Bekir","family":"Demirta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3386-971X","authenticated-orcid":false,"given":"As\u0131f","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"3968_CR1","first-page":"203","volume":"14","author":"HO Lithell","year":"1991","unstructured":"Lithell HO (1991) Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. DiabetesCare 14:203\u2013209","journal-title":"DiabetesCare"},{"key":"3968_CR2","first-page":"1258","volume":"11","author":"S Jacop","year":"1998","unstructured":"Jacop S, Rett K, Henriksen EJ (1998) Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of \u03b2-blocking agents? AJH 11:1258\u20131265","journal-title":"AJH"},{"key":"3968_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2337\/diab.44.6.665","volume":"44","author":"M Giordano","year":"1995","unstructured":"Giordano M, Matsuda M, Sanders L, Canessa ML, DeFronzo RA (1995) Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes 44:665\u2013671","journal-title":"Diabetes"},{"key":"3968_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tcm.2018.08.001","volume":"29","author":"G Fragasso","year":"2019","unstructured":"Fragasso G, Margonato A, Spoladore R, Lopaschuk GD (2019) Metabolic effects of cardiovascular drugs. Trends Cardiovasc Med 29:176\u2013187. https:\/\/doi.org\/10.1016\/j.tcm.2018.08.001","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"3968_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamaneurol.2020.5157","volume":"78","author":"JE Simmering","year":"2021","unstructured":"Simmering JE, Welsh MJ, Liu L, Narayanan NS, Potteg\u00e5rd A (2021) Association of glycolysis-enhancing \u03b1-1 blockers with risk of developing parkinson disease. JAMA Neurol 78(4):407\u2013413. https:\/\/doi.org\/10.1001\/jamaneurol.2020.5157","journal-title":"JAMA Neurol"},{"issue":"2A","key":"3968_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/0002-9343(84)90959-8","volume":"76","author":"Y Goto","year":"1984","unstructured":"Goto Y (1984) Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial. Am J Med 76(2A):72\u201378. https:\/\/doi.org\/10.1016\/0002-9343(84)90959-8","journal-title":"Am J Med"},{"issue":"11","key":"3968_CR7","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/0026-0495(93)90196-u","volume":"42","author":"C Giorda","year":"1993","unstructured":"Giorda C, Appendino M (1993) Effects of doxazosin, a selective alpha 1-inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension. Metabolism 42(11):1440\u20131442. https:\/\/doi.org\/10.1016\/0026-0495(93)90196-u","journal-title":"Metabolism"},{"issue":"5","key":"3968_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0026-0495(95)90127-2","volume":"44","author":"C Giorda","year":"1995","unstructured":"Giorda C, Appendino M, Mason MG, Imperiale E, Pagano G (1995) Alpha 1-blocker doxazosin improves peripheral insulin sensitivity in diabetic hypertensive patients. Metabolism 44(5):673\u2013676. https:\/\/doi.org\/10.1016\/0026-0495(95)90127-2","journal-title":"Metabolism"},{"issue":"4","key":"3968_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/BF02220610","volume":"43","author":"R Huupponen","year":"1992","unstructured":"Huupponen R, Lehtonen A, V\u00e4h\u00e4talo M (1992) Effect of doxazosin on insulin sensitivity in hypertensive non-insulin dependent diabetic patients. Eur J ClinPharmacol 43(4):365\u2013368. https:\/\/doi.org\/10.1007\/BF02220610","journal-title":"Eur J ClinPharmacol"},{"issue":"3","key":"3968_CR10","first-page":"141","volume":"68","author":"S Borgsteede","year":"2010","unstructured":"Borgsteede S, Bruggeman R, Hoefnagel R, Huiskes M, vanPuijenbroek E (2010) Tamsulosin and hyperglycaemia in patients with diabetes. Neth J Med 68(3):141\u2013143","journal-title":"Neth J Med"},{"issue":"2","key":"3968_CR11","first-page":"187","volume":"35","author":"M Dikko","year":"2020","unstructured":"Dikko M, Sarkingobir Y, Umar AI (2020) Effect of tamsulosin administration on oral glucose tolerance (OGT) in normal wistar rats. Niger J PhysiolSci 35(2):187\u2013190","journal-title":"Niger J PhysiolSci"},{"issue":"8","key":"3968_CR12","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.18203\/2319-2003.ijbcp20183030","volume":"7","author":"S Satpute","year":"2018","unstructured":"Satpute S, Nerurkar R, Kokne M (2018) Effect of tamsulosin on blood glucose levels in euglycemic and all oxan induced diabetic rats and its interaction with glibenclamide. Int J Basic ClinPharmacol 7(8):1599\u20131605. https:\/\/doi.org\/10.18203\/2319-2003.ijbcp20183030","journal-title":"Int J Basic ClinPharmacol"},{"key":"3968_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4314\/jasem.v24i4.1","volume":"24","author":"M Dikko","year":"2020","unstructured":"Dikko M, Bello SO, Chika A, Mungadi IA, Sarkingobir Y, Umar AI (2020) Effect of tamsulosin use on plasma insulin status in benign prostatic hyperplasia patients in sokoto. Nigeria J ApplSciEnvironManage 24:543\u2013548. https:\/\/doi.org\/10.4314\/jasem.v24i4.1","journal-title":"Nigeria J ApplSciEnvironManage"},{"key":"3968_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"issue":"4","key":"3968_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1517\/14728222.2012.664135","volume":"16","author":"U Saxena","year":"2012","unstructured":"Saxena U (2012) Bioenergetics failure in neurodegenerative diseases: back to the future. ExpertOpinTherTargets 16(4):351\u2013354. https:\/\/doi.org\/10.1517\/14728222.2012.664135","journal-title":"ExpertOpinTherTargets"},{"issue":"19","key":"3968_CR16","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ (2018) Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBSJ 285(19):3657\u20133668. https:\/\/doi.org\/10.1111\/febs.14607","journal-title":"FEBSJ"},{"issue":"5646","key":"3968_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J et al (2003) alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302(5646):841. https:\/\/doi.org\/10.1126\/science.1090278","journal-title":"Science"},{"issue":"6339","key":"3968_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.aaf6846","volume":"356","author":"A Patel","year":"2017","unstructured":"Patel A, Malinovska L, Saha S et al (2017) ATP as a biological hydrotrope. Science 356(6339):753\u2013756. https:\/\/doi.org\/10.1126\/science.aaf6846","journal-title":"Science"},{"issue":"10","key":"3968_CR19","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI129987","volume":"129","author":"R Cai","year":"2019","unstructured":"Cai R, Zhang Y, Simmering JE et al (2019) Enhancing glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases. J ClinInvest 129(10):4539\u20134549. https:\/\/doi.org\/10.1172\/JCI129987","journal-title":"J ClinInvest"},{"key":"3968_CR20","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S0895-7061(01)02141-0","volume":"14","author":"T Hirano","year":"2001","unstructured":"Hirano T, Yoshino G, Kashiwazaki K, Adachi M (2001) Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients. Am J Hypertens 14:908\u2013913","journal-title":"Am J Hypertens"},{"issue":"1","key":"3968_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/080370598437556","volume":"7","author":"LN Daae","year":"1998","unstructured":"Daae LN, Westlie L (1998) A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk. Blood Press 7(1):39\u201345. https:\/\/doi.org\/10.1080\/080370598437556","journal-title":"Blood Press"},{"issue":"9","key":"3968_CR22","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1097\/HJH.0b013e32833b912c","volume":"28","author":"N Chapman","year":"2010","unstructured":"Chapman N, Chen CY, Fujita T et al (2010) Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension? JHypertens 28(9):1796\u20131803. https:\/\/doi.org\/10.1097\/HJH.0b013e32833b912c","journal-title":"JHypertens"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-03968-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-03968-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-03968-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:41:21Z","timestamp":1745901681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-03968-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3968"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-03968-z","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"2 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}